Product Name:

NebuPeptide™ Atosiban Acetate (Peptide Reference)

Catalog Number:

NBS-233788

Description:

NebuPeptide™ Atosiban Acetate (Peptide Reference)(CAT#NBS-233788) is synthesized in accordance with the Atosiban Acetate sequence and can be utilized for a variety of in vivo and in vitro studies, including quality control, bioactivity verification, immunization, drug development, structural analysis, etc. Nebula Biotechnology Co., Ltd. is capable of providing Voclosporin reference peptide ranging from milligrams to kilograms.

Peptide Name:

Atosiban Acetate (醋酸阿托西班)

Background:

Atosiban acetate, the acetate salt of Atosiban (RW-22164; Tractocile; RWJ22164), is a novel and potent peptide-based oxytocin and vasopressin antagonist with the potential to be used for spontaneous preterm labor. It is a desamino-oxytocin analogue that is nonapeptide and a competitive antagonist of the vasopressin/oxytocin receptor (VOTra). Atosiban blocks the release of inositol trisphosphate from the myometrial cell membrane, which is mediated by oxytocin.

Alias:

ORF-22164; RWJ 22164; ORF 22164; RWJ22164; ORF22164; RWJ-22164; Atosiban; Tractocile; Antocin

CAS Number:

914453-95-5/90779-69-4

Formula:

C45H71N11O14S2

Molecular Weight:

1054.2

Purity:

see COA

Solubility:

see COA

Storage & Shipment:

Store at -20℃; ship with blue ice.

For R&D use only!

To get more information, please contact us freely.